Suppr超能文献

急性和慢性丙型肝炎病毒感染的小鼠模型

Mouse models of acute and chronic hepacivirus infection.

作者信息

Billerbeck Eva, Wolfisberg Raphael, Fahnøe Ulrik, Xiao Jing W, Quirk Corrine, Luna Joseph M, Cullen John M, Hartlage Alex S, Chiriboga Luis, Ghoshal Kalpana, Lipkin W Ian, Bukh Jens, Scheel Troels K H, Kapoor Amit, Rice Charles M

机构信息

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Science. 2017 Jul 14;357(6347):204-208. doi: 10.1126/science.aal1962.

Abstract

An estimated 71 million people worldwide are infected with hepatitis C virus (HCV). The lack of small-animal models has impeded studies of antiviral immune mechanisms. Here we show that an HCV-related hepacivirus discovered in Norway rats can establish high-titer hepatotropic infections in laboratory mice with immunological features resembling those seen in human viral hepatitis. Whereas immune-compromised mice developed persistent infection, immune-competent mice cleared the virus within 3 to 5 weeks. Acute clearance was T cell dependent and associated with liver injury. Transient depletion of CD4 T cells before infection resulted in chronic infection, characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecules on intrahepatic CD8 T cells. Natural killer cells controlled early infection but were not essential for viral clearance. This model may provide mechanistic insights into hepatic antiviral immunity, a prerequisite for the development of HCV vaccines.

摘要

据估计,全球有7100万人感染丙型肝炎病毒(HCV)。缺乏小动物模型阻碍了对抗病毒免疫机制的研究。在此,我们表明在挪威大鼠中发现的一种与HCV相关的肝病毒可在实验室小鼠中建立高滴度嗜肝感染,其免疫特征类似于人类病毒性肝炎。免疫功能低下的小鼠发生持续感染,而免疫功能正常的小鼠在3至5周内清除病毒。急性清除依赖于T细胞,并与肝损伤相关。感染前CD4 T细胞的短暂耗竭导致慢性感染,其特征是肝内调节性T细胞水平高以及肝内CD8 T细胞上抑制分子的表达。自然杀伤细胞控制早期感染,但对病毒清除并非必不可少。该模型可能为肝脏抗病毒免疫提供机制性见解,这是开发HCV疫苗的先决条件。

相似文献

1
Mouse models of acute and chronic hepacivirus infection.
Science. 2017 Jul 14;357(6347):204-208. doi: 10.1126/science.aal1962.
3
Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.
Nat Commun. 2019 Mar 7;10(1):1113. doi: 10.1038/s41467-019-09105-0.
4
T cell responses in hepatitis C virus infection: historical overview and goals for future research.
Antiviral Res. 2015 Feb;114:96-105. doi: 10.1016/j.antiviral.2014.11.009. Epub 2014 Nov 26.
5
Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
J Virol. 2015 May;89(10):5478-90. doi: 10.1128/JVI.03717-14. Epub 2015 Mar 4.
6
Cellular immune responses against hepatitis C virus.
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S25-31. doi: 10.1086/429492.
7
[Adaptive cell immune response against the hepatitis C virus infection].
Med Clin (Barc). 2007 Oct 6;129(12):469-76. doi: 10.1157/13111005.
9
Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
J Virol. 2023 Apr 27;97(4):e0181222. doi: 10.1128/jvi.01812-22. Epub 2023 Mar 27.

引用本文的文献

2
The PD-1/PD-L1 pathway and Epstein-Barr virus.
Eur J Med Res. 2025 Jun 18;30(1):486. doi: 10.1186/s40001-025-02694-1.
3
6
Mice Engrafted with Human Liver Cells.
Semin Liver Dis. 2024 Nov;44(4):405-415. doi: 10.1055/s-0044-1790601. Epub 2024 Sep 12.
7
Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.
PLoS Pathog. 2024 Aug 28;20(8):e1012436. doi: 10.1371/journal.ppat.1012436. eCollection 2024 Aug.
9
An immunogenetic basis for lung cancer risk.
Science. 2024 Feb 23;383(6685):eadi3808. doi: 10.1126/science.adi3808.
10
New insights into the downregulation of cytochrome P450 2E1 via nuclear factor κB-dependent pathways in immune-mediated liver injury.
Heliyon. 2023 Nov 19;9(12):e22641. doi: 10.1016/j.heliyon.2023.e22641. eCollection 2023 Dec.

本文引用的文献

2
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.
Adv Exp Med Biol. 2015;850:137-52. doi: 10.1007/978-3-319-15774-0_10.
3
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
Curr Opin Immunol. 2015 Aug;35:137-43. doi: 10.1016/j.coi.2015.06.010. Epub 2015 Aug 1.
5
Overcoming T cell exhaustion in infection and cancer.
Trends Immunol. 2015 Apr;36(4):265-76. doi: 10.1016/j.it.2015.02.008. Epub 2015 Mar 18.
6
Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.
Antiviral Res. 2015 Mar;115:83-93. doi: 10.1016/j.antiviral.2014.12.014. Epub 2014 Dec 26.
7
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
Front Immunol. 2014 Nov 10;5:550. doi: 10.3389/fimmu.2014.00550. eCollection 2014.
9
The ins and outs of hepatitis C virus entry and assembly.
Nat Rev Microbiol. 2013 Oct;11(10):688-700. doi: 10.1038/nrmicro3098. Epub 2013 Sep 10.
10
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15001-6. doi: 10.1073/pnas.1312772110. Epub 2013 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验